文献速递关节外科创伤骨科小儿骨科

Schanz截骨后Crowe IV型髋关节发育不良的全髋关节置换联合转子下截骨:平均11年随访的患者满意度与结局

Patient Satisfaction and Outcomes at a Mean 11-Year Follow-Up Following Total Hip Arthroplasty With Subtrochanteric Osteotomy for Dislocated Hips After Schanz Osteotomy.
PubMed 文献 · J Arthroplasty · 2026-07-04

本研究回顾性分析73例(93髋)Crowe IV型髋关节脱位且既往行Schanz截骨的患者,接受全髋关节置换联合转子下截骨,平均随访11年。JOA髋关节评分中位数从49改善至86(P<0.001),10年和20年假体生存率均为88.9%(95%CI 82.0-95.9),90%的患者满意。术前使用助行器与功能结果差和满意度低相关。

要点

  • 全髋关节置换联合转子下截骨可显著改善Schanz截骨后Crowe IV型髋脱位患者的功能和满意度。
  • 假体生存率在10年和20年均为88.9%,8.4年后无翻修病例。
  • 术前使用助行器与功能结果差(OR 12.21)和不满意(OR 13.08)相关。

核心结论

  • 对于Schanz截骨后Crowe IV型髋关节脱位,全髋关节置换联合转子下截骨可改善功能并提高患者满意度,假体生存率可接受,但并发症和翻修率仍较高。
  • 术前使用助行器与功能结果差和患者不满意相关,但估计精度有限。

研究设计与样本

  • 回顾性研究,纳入73例(93髋)因Crowe IV型髋关节脱位既往行Schanz截骨并接受全髋关节置换联合转子下截骨的患者。
  • 分析假体生存率(以任何原因翻修为终点)和功能结果差(JOA髋关节评分<70)的预测因素;在完成PROM问卷的55例(71髋,应答率75%)中分析不满意(VAS<50)的相关因素。
  • 多因素分析采用偏倚减少的logistic回归模型以处理有限事件数。

主要发现

  • JOA髋关节评分中位数从术前49(四分位距41-62)改善至平均随访11年(范围2.0-21年)时的86(四分位距76-93),P<0.001。
  • Kaplan-Meier假体生存率在10年和20年均为88.9%(95%CI 82.0-95.9),术后8.4年后无翻修。
  • 多因素分析显示术前使用助行器与功能结果差相关(OR 12.21;95%CI 1.35-1615.31;P=0.013)。
  • 在PROM队列中,71髋中64髋(90%)满意,术前使用助行器与不满意相关(OR 13.08;95%CI 1.28-1774.59;P=0.016)。

关键数值与推荐

  • 功能结果差定义为JOA髋关节评分<70。
  • 不满意定义为VAS<50。
  • 假体生存率10年和20年均为88.9%(95%CI 82.0-95.9)。

临床怎么用

  • 对于Schanz截骨后Crowe IV型髋脱位患者,全髋关节置换联合转子下截骨可作为一种改善功能和满意度的治疗选择,但需告知并发症和翻修风险较高。
  • 术前使用助行器可能提示术后功能结果差和满意度低的风险较高,应加强围手术期管理和患者预期沟通。

局限性

  • 回顾性设计。
  • PROM随访不完整(应答率75%)。
  • 需要前瞻性多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip arthroplasty (THA) for chronically dislocated hips after Schanz osteotomy is technically demanding, with limited data on outcomes and patient satisfaction. This study aimed to determine clinical outcomes, implant survivorship, and factors associated with poor functional outcome and dissatisfaction after THA with subtrochanteric osteotomy. METHODS: We retrospectively reviewed 73 patients (93 hips) who had Crowe IV dislocation treated with Schanz osteotomy and who underwent THA with subtrochanteric osteotomy. Implant survival (revision for any reason as the end point) and predictors of poor functional outcome (Japanese Orthopaedic Association hip score less than 70) were analyzed. Factors associated with dissatisfaction (visual analog scale less than 50) were analyzed in patients who completed patient-reported outcome measure (PROM) questionnaires (55 patients, 71 hips; 75% response rate). Multivariate analyses used bias-reduced logistic regression models for limited events. RESULTS: The median Japanese Orthopaedic Association score improved from 49 (interquartile range, 41 to 62) to 86 (interquartile range, 76 to 93) at a mean follow-up of 11 years (range, 2.0 to 21; P < 0.001). Kaplan-Meier implant survivorship was 88.9% (95% confidence interval [CI], 82.0 to 95.9) at both 10 and 20 years, with no revisions beyond 8.4 years postoperatively. Multivariate analyses showed that preoperative mobility aid use was associated with poor functional outcome (odds ratio, 12.21; 95% CI, 1.35 to 1,615.31; P = 0.013). In the PROM cohort, 64 of 71 hips (90%) were satisfied, and preoperative mobility aid use was associated with dissatisfaction (odds ratio, 13.08; 95% CI, 1.28 to 1,774.59; P = 0.016). CONCLUSIONS: A THA for Crowe IV dislocation after Schanz osteotomy improved function and patient satisfaction, with acceptable implant survivorship; however, complication and revision rates remained substantial. Preoperative mobility aid use was associated with poor outcomes, although estimates showed limited precision. The retrospective design and incomplete PROM follow-up warrant prospective multicenter validation.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fujii M, Kawano S, Ueno M, et al. Patient Satisfaction and Outcomes at a Mean 11-Year Follow-Up Following Total Hip Arthroplasty With Subtrochanteric Osteotomy for Dislocated Hips After Schanz Osteotomy. J Arthroplasty. 2026. PMID: 42401353. doi:10.1016/j.arth.2026.06.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。